Cellceutix (CTIX)

Add to Watchlists
Create an Alert
1.59 +0.00  +0.00% OTC Markets Apr 24, 3:27PM Delayed by 15 min Currency in USD
View Full Chart
CTIX Price Chart
View All Performance Charts

CTIX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cellceutix is up 1.92% over the last year vs S&P 500 Total Return up 21.54%, Cubist Pharmaceuticals up 41.63%, and ARCA biopharma down 36.82%.

Get Quote for

Portfolio Strategies Featuring CTIX

Did Cellceutix make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CTIX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Cellceutix Corporation is in the business of developing innovative small molecule therapies to treat diseases with significant medical need, particularly in the areas of cancer and inflammatory disease.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CTIX 1.59 +0.00 +0.00% 168.34M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.